Health
New York: GlaxoSmithKline plc and Vir Biotechnology, Inc. on Tuesday announced an update to preclinical data on bioRxiv, a preprint server, demonstrating that sotrovimab, an investigational monoclonal antibody, retains in vitro activity against the full known Omicron spike protein, the new SARS-CoV-2 variant (B.1.1.529). more
GSK organises conference on Congenital Hypothyroidism in Kolkata
Kolkata, Aug 8 (Just Earth News): GSK or Glaxo Smith Kline, a British pharmaceutical company headquartered in London, organised a panel discussion on Congenital Hypothyroidism in Kolkata on ...
